Literature DB >> 14532270

A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death.

Yuzuru Imai1, Mariko Soda, Tetsuro Murakami, Mikio Shoji, Koji Abe, Ryosuke Takahashi.   

Abstract

Parkin, a RING-type ubiquitin ligase, is the product of the gene responsible for autosomal recessive juvenile parkinsonism. A reverse strand gene located upstream of the parkin gene in the human genome has been identified. The gene product, termed Glup/PACRG, forms a large molecular chaperone complex containing heat shock proteins 70 and 90 and chaperonin components. Glup suppressed cell death induced by accumulation of unfolded Pael receptor (Pael-R), a substrate of Parkin. On the other hand, Glup facilitated the formation of inclusions consisting of Pael-R, molecular chaperones, protein degradation molecules, and Glup itself, when proteasome is inhibited. Glup knockdown attenuated the formation of Pael-R inclusions, which resulted in the promotion of cell death with extensive vacuolization. Moreover, Glup turned out to be a component of Lewy bodies in Parkinson's disease cases. These data suggest that Glup may play an important role in the formation of Lewy bodies and protection of dopaminergic neurons against Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532270     DOI: 10.1074/jbc.M309655200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Downregulation of parkin damages antioxidant defenses and enhances proteasome inhibition-induced toxicity in PC12 cells.

Authors:  Hui Yang; Hai-Yan Zhou; Biao Li; Guo-Zhong Niu; Sheng-Di Chen
Journal:  J Neuroimmune Pharmacol       Date:  2007-07-20       Impact factor: 4.147

2.  Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.

Authors:  R Pattarini; Y Rong; C Qu; J I Morgan
Journal:  Neuroscience       Date:  2008-07-08       Impact factor: 3.590

3.  PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever.

Authors:  S Ali; A M Vollaard; S Widjaja; C Surjadi; E van de Vosse; J T van Dissel
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

Review 4.  The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.

Authors:  Mario Di Napoli; BethAnn McLaughlin
Journal:  Curr Opin Investig Drugs       Date:  2005-07

5.  Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease.

Authors:  Chiara Monti; Ilaria Colugnat; Leonardo Lopiano; Adriano Chiò; Tiziana Alberio
Journal:  Mol Neurobiol       Date:  2016-12-21       Impact factor: 5.590

6.  Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death.

Authors:  Duong P Huynh; Dung T Nguyen; Johannes B Pulst-Korenberg; Alexis Brice; Stefan-M Pulst
Journal:  Exp Neurol       Date:  2006-11-09       Impact factor: 5.330

7.  Deletion of the Parkin coregulated gene causes male sterility in the quaking(viable) mouse mutant.

Authors:  Diego Lorenzetti; Colin E Bishop; Monica J Justice
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

8.  RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player.

Authors:  K Häbig; M Walter; S Poths; O Riess; M Bonin
Journal:  Neurogenetics       Date:  2007-12-21       Impact factor: 2.660

Review 9.  How does parkin ligate ubiquitin to Parkinson's disease?

Authors:  Philipp J Kahle; Christian Haass
Journal:  EMBO Rep       Date:  2004-07       Impact factor: 8.807

10.  The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBAC.

Authors:  Jens Meschede; Maria Šadić; Nikolas Furthmann; Tim Miedema; Dominik A Sehr; A Kathrin Müller-Rischart; Verian Bader; Lena A Berlemann; Anna Pilsl; Anita Schlierf; Katalin Barkovits; Barbara Kachholz; Katrin Rittinger; Fumiyo Ikeda; Katrin Marcus; Liliana Schaefer; Jörg Tatzelt; Konstanze F Winklhofer
Journal:  Sci Signal       Date:  2020-02-04       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.